Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2020-12-24 / Cancers (Basel) 2020 Dec;13(1)A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs)
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2020-11-17 / Cancers (Basel) 2020 Nov;12(11)Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine
/in Breast Cancer, Dendritic Cells, International Publications /von 2020-10-27 / Front Oncol 2020;10:605633High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2020-10-26 / Front Oncol 2020;10:536700Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2020-10-14 / Nat Commun 2020 10;11(1):5173Dendritic Cell-based Immunotherapy Pulsed With Wilms Tumor 1 Peptide and Mucin 1 as an Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Phase I/IIa Clinical Trial
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2020-10-01 / Anticancer Res 2020 Oct;40(10):5765-5776Pilot study on outcome and antitumor efficacy of an autologous cancer cell vaccine applied in patients with advanced solid tumors.
/in Dendritic Cells, International Publications /von 2020-08-31 / J Clin Oncol 38: 2020 (suppl; abstr 3000)The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2020-08-13 / Immunotherapy 2020 Aug;A dendritic cell multitasks to tackle cancer
/in Dendritic Cells, International Publications /von 2020-08-12 / Nature 2020 Aug;IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de